Signal-based automated deep brain stimulation programming

Automatically adjust the value of the electrical stimulation treatment parameter through titration technology, and use processing circuits to determine the orientation of the signal source in the brain and the current density of the electrodes, solving the problem of the cumbersome process of determining the parameters of the electrical stimulation treatment in the prior art, improving the accuracy of the treatment and efficiency.

CN113195046BActive Publication Date: 2024-12-03MEDTRONIC INC
View PDF 14 Cites 0 Cited by

Patent Information

Application Number
CN201980070947.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2018-10-26
Filing Date
2019-06-26
Publication Date
2024-12-03
Estimated Expiration
2039-06-26

AI Technical Summary

Technical Problem

Existing electrical stimulation therapy devices require a long trial and error process when automatically determining the treatment parameter values, and it is difficult to quickly adapt to changes in the signal source in the patient's body, affecting the treatment effect.

Method used

The treatment parameter value of electrical stimulation is automatically adjusted through titration technology, and the processing circuit is used to determine the orientation of the signal source in the brain and the current density of the electrodes, and iteratively adjust the parameters of the electrodes until the power difference is less than the threshold to determine the most suitable treatment parameter value.

Benefits of technology

The rapid determination of appropriate treatment parameter values ​​is achieved, reducing trial and error processes between clinicians and patients, and improving the accuracy and efficiency of treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113195046B_ABST
    Figure CN113195046B_ABST
Patent Text Reader

Abstract

The present invention discloses a technique for automatically determining a treatment parameter value for adaptive deep brain stimulation (aDBS). A medical device may determine a difference in power value between a current power value and a previous power value. Based on the difference being greater than or equal to a threshold, the medical device may iteratively adjust the current treatment parameter value until the difference in power value between the current power value and the previous power value is less than the threshold.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure relates generally to electrical stimulation therapy. Background Art

[0002] The medical device may be external or implanted, and may be used to deliver electrical stimulation therapy to various tissue sites of a patient to treat a variety of symptoms or conditions, such as chronic pain, tremor, Parkinson's disease, other movement disorders, epilepsy, urinary or fecal incontinence, sexual dysfunction, obesity or gastroparesis. The present invention discloses a medical device that delivers electrical stimulation therapy via one or more leads, the one or more leads comprising electrodes located near a target location associated with the patient's brain, spinal cord, pelvic nerves, peripheral nerves or gastrointestinal tract. For bipolar stimulation, the electrodes used for stimulation may be on one or more leads. For monopolar stimulation, the electrodes may be on one or more leads, and the electrodes on the stimulator housing are located away from the target site (e.g., near the clavicle). Leadless stimulation may be used using electrodes mounted on the stimulation housing. Therefore, electrical stimulation is used for different therapeutic applications, such as adaptive deep brain stimulation (aDBS), spinal cord stimulation (SCS), pelvic stimulation, gastric stimulation or peripheral nerve field stimulation (PNFS).

[0003] The clinician can select values ​​for a plurality of programmable parameters in order to define the electrical stimulation therapy to be delivered to the patient by the implantable stimulator. For example, the clinician can select one or more electrodes for delivering the stimulation, the polarity of each selected electrode, the voltage or current pulse amplitude, the pulse width, and the pulse frequency as stimulation parameters. A set of parameters (such as a set of parameters including electrode combinations, electrode polarity, amplitude, pulse width, and pulse frequency) can be referred to as a program because the set of parameters defines the electrical stimulation therapy to be delivered to the patient. Summary of the invention

[0004] The present disclosure describes an exemplary technique for titrating treatment parameters for automatic stimulation programming so that the delivery of electrical stimulation based on the treatment parameters compensates for the effects of a signal source in the patient's body. In adaptive deep brain stimulation (aDBS), a medical device (e.g., an implantable medical device (IMD) or a programmer) can determine which electrodes are closest to a signal source in the patient's body. The electrode closest to the signal source is often the electrode used to deliver treatment, such as in terms of therapeutic efficacy in terms of relieving a condition associated with the signal source. The present disclosure describes an exemplary technique for determining treatment parameters for treatment delivery using electrodes close to the signal source. For example, a medical device can (e.g., in response to the delivery of a previous electrical stimulation) determine the difference between the power of a frequency band and the previous power of the frequency band, and determine whether the difference is less than or greater than a difference threshold. The medical device can continuously adjust the treatment parameter value until the difference between the power of the frequency band and the previous power of the frequency band is less than the difference threshold. The final treatment parameter value can be a parameter value that causes the difference to be less than the difference threshold. Then, the IMD can deliver treatment based on the final treatment parameter value. In some examples, a physician or clinician may be required to confirm a final therapy parameter value before the IMD delivers therapy based on the final therapy parameter value.

[0005] In this way, the exemplary technology can provide a relatively quick way to determine the value of a treatment parameter to provide a technical solution to the technical problem of determining an appropriate treatment parameter value. For example, instead of manually inputting different treatment parameters and receiving patient feedback on efficacy, the medical device can automatically perform the process of determining the treatment parameter value based on whether the difference between the current power and the previous power of the frequency band is greater than or less than a difference threshold.

[0006] In one example, the present disclosure describes a method comprising: determining, using a processing circuit, a current power value of power in a frequency band in a bioelectric signal generated in the brain in response to delivery of a current electrical stimulation having a current treatment parameter value; determining, using the processing circuit, a power band difference between the current power value and a previous power value, wherein the previous power value indicates power in a frequency band in a previous bioelectric signal generated in the brain in response to delivery of a previous electrical stimulation, the previous electrical stimulation having a previous treatment parameter value different from the current treatment parameter value; comparing, using the processing circuit, the power band difference with a threshold; based on the power band difference being greater than or equal to the threshold, iteratively setting, using the processing circuit, the previous treatment parameter value to be equal to the current treatment parameter value, and adjusting, using the processing circuit, the current treatment parameter value until the power band difference is less than the threshold; setting, using the processing circuit, a final treatment parameter value based on the current treatment parameter value; and delivering, using the processing circuit, an electrical stimulation having the final treatment parameter value.

[0007] In one example, the present disclosure describes a system including a medical device, the medical device including a memory and a processing circuit. The processing circuit is configured to: determine a current power value of power in a frequency band in a bioelectric signal generated in the brain in response to the delivery of a current electrical stimulation having a current treatment parameter value; determine a power band difference between the current power value and a previous power value, wherein the previous power value indicates the power in a frequency band in a previous bioelectric signal generated in the brain in response to the delivery of a previous electrical stimulation, the previous electrical stimulation having a previous treatment parameter value different from the current treatment parameter value, and wherein the power value is stored in the memory; compare the power band difference with a threshold; based on the power band difference being greater than or equal to the threshold, iteratively set the previous treatment parameter value to be equal to the current treatment parameter value, and adjust the current treatment parameter value until the power band difference is less than the threshold; set a final treatment parameter value based on the current treatment parameter value; and cause the delivery of electrical stimulation having the final treatment parameter value.

[0008] In one example, the present disclosure describes a computer-readable storage medium storing instructions that, when executed, cause one or more processors of a medical device to: determine a current power value for power in a frequency band in a bioelectric signal generated in the brain in response to delivery of a current electrical stimulation having a current treatment parameter value; determine a power band difference between the current power value and a previous power value, wherein the previous power value indicates power in a frequency band in a previous bioelectric signal generated in the brain in response to delivery of a previous electrical stimulation having a previous treatment parameter value different from the current treatment parameter value; compare the power band difference with a threshold; based on the power band difference being greater than or equal to the threshold, iteratively set the previous treatment parameter value to be equal to the current treatment parameter value, and adjust the current treatment parameter value until the power band difference is less than the threshold; set a final treatment parameter value based on the current treatment parameter value; and cause delivery of electrical stimulation having the final treatment parameter value.

[0009] The details of one or more examples of the techniques of this disclosure are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of these techniques will be apparent from the description and drawings, and from the claims. BRIEF DESCRIPTION OF THE DRAWINGS

[0010] Figure 1 is a conceptual diagram illustrating an exemplary system including an implantable medical device (IMD) configured to deliver adaptive DBS to a patient in accordance with examples of the presently disclosed technology.

[0011] Figure 2 is an example of a method for delivering adaptive DBS therapy according to the technology disclosed herein Figure 1 Block diagram of an exemplary IMD.

[0012] Figure 3 is a method for controlling the delivery of adaptive DBS therapy according to an example of the technology disclosed herein Figure 1 Block diagram of an external programmer.

[0013] FIG. 4A to FIG. 4C is a conceptual diagram illustrating exemplary operations for determining a therapy parameter value according to an example of the presently disclosed technology.

[0014] Figure 5 is a flow chart illustrating exemplary operations according to the technology of this disclosure. DETAILED DESCRIPTION

[0015] The present disclosure describes exemplary techniques for automatically determining electrical stimulation therapy parameter values ​​(such as electrical stimulation amplitude values) for treatment after determining which electrodes are used for treatment. In some examples, an implantable medical device (IMD) determines the orientation of a signal source in the brain relative to a lead, and determines the electrode on the lead that is closest to the signal source. As described in more detail, as a non-limiting example, the closest electrode on the lead is determined to be the above-mentioned electrode by determining the electrode with the highest current source density (CSD). The electrode determined to be closest to the signal source is the electrode selected for delivering treatment. However, once the orientation of the signal source and which electrodes are closest to the signal source are known, clinicians may need to go through a lengthy trial and error process to find appropriate values ​​for the treatment parameters (such as amplitude) of the treatment to be delivered via the closest electrode.

[0016] The present disclosure describes exemplary techniques that combine techniques for determining which electrode to use to deliver therapy once a signal orientation is found with techniques for automatically determining therapy parameters. For example, in step one, a medical device (e.g., an IMD or programmer) determines source orientation and selects electrodes to be used to deliver therapy based on that determination. In step two, the medical device deploys an adaptive stimulation protocol on the selected electrodes to titrate one or more parameters of stimulation for suppressing beta band signal power in the brain.

[0017] The IMD or programmer may titrate one or more of the treatment parameters using various exemplary techniques. As an example, the amplitude of the stimulation therapy is gradually adjusted (e.g., increased) until the difference between the current beta band signal power and the previous beta band signal power, for example, obtained from a local field potential (LFP) signal, is less than a predetermined threshold difference, or until the patient experiences undesirable side effects. The IMD or programmer may set the amplitude value of the stimulation therapy to be equal to the current amplitude value produced at the current beta band signal power. In one example, to gradually adjust the amplitude, the IMD or programmer may adjust the amplitude according to a binary search algorithm, as described in more detail. However, other algorithms may be used in addition to or in place of the binary search algorithm.

[0018] Figure 1 is a conceptual diagram illustrating an exemplary system 100 that includes an implantable medical device (IMD) 106 configured to deliver adaptive deep brain stimulation to a patient 112. DBS may be adaptive because the IMD 106 may adjust, increase, or decrease the magnitude of one or more parameters of DBS in response to changes in patient activity or movement, severity of one or more symptoms of the patient's disease, presence of one or more side effects due to DBS, or one or more sensed signals from the patient.

[0019] For example, one example of system 100 is a bidirectional DBS system with the ability to both deliver stimulation and sense intrinsic neuronal signals. System 100 provides a "closed loop" therapy in which IMD 106 can continuously monitor the status of certain biomarker signals and deliver stimulation according to a pre-programmed routine based on those biomarker signals.

[0020] System 100 can be configured to treat patient conditions, such as movement disorders, neurodegenerative damage, mood disorders or epilepsy of patient 112. Patient 112 is usually a human patient. However, in some cases, treatment system 100 can be applied to other mammals or non-mammals, non-human patients. Although movement disorders and neurodegenerative damage are mainly mentioned herein, in other examples, treatment system 100 can provide treatment to manage the symptoms of other patient conditions, such as but not limited to epilepsy (e.g., epilepsy) or mood (or psychological) disorders (e.g., major depressive disorder (MDD), bipolar disorder, anxiety disorder, post-traumatic stress disorder, dysthymia and obsessive-compulsive disorder (OCD)). At least some of these obstacles can be manifested as one or more patient motor behaviors. As described herein, movement disorders or other neurodegenerative damages can include symptoms, such as muscle control damage, motor damage or other motor problems, such as stiffness, spasticity, bradykinesia, rhythmic hyperkinesia, non-rhythmic hyperkinesia and akinesia. In some cases, movement disorders can be the symptoms of Parkinson's disease. However, movement disorders may be attributable to other patient conditions.

[0021] The exemplary treatment system 100 includes a medical device programmer 104, an implantable medical device (IMD) 106, a lead extension 110, and leads 114A and 114B having a corresponding set of electrodes 116, 118. Figure 1 In the example shown, the electrodes 116, 118 of the leads 114A, 114B are positioned to deliver electrical stimulation to a tissue site within the brain 120, such as a deep brain site below the dura mater of the brain 120 of the patient 112. In some examples, delivering stimulation to one or more regions of the brain 120, such as the subthalamic nucleus, globus pallidus, or thalamus, can be an effective treatment for managing movement disorders such as Parkinson's disease. Some or all of the electrodes 116, 118 may also be positioned to sense neural brain signals within the brain 120 of the patient 112. In some examples, some of the electrodes 116, 118 may be configured to sense neural brain signals, and other electrodes 116, 118 may be configured to deliver adaptive electrical stimulation to the brain 120. In other examples, all of the electrodes 116, 118 are configured to sense neural brain signals and deliver adaptive electrical stimulation to the brain 120. In some examples, monopolar stimulation is possible with one electrode located on the housing of the IMD 106.

[0022] IMD 106 includes a therapy module (e.g., which may include processing circuits, signal generation circuits, or other circuits configured to perform functions attributed to IMD 106) that includes a stimulation generator configured to generate and deliver electrical stimulation therapy to patient 112 via a subset of electrodes 116, 118 of leads 114A and 114B, respectively. The subset of electrodes 116, 118 used to deliver electrical stimulation to patient 112, and in some cases, the polarity of the subset of electrodes 116, 118, may be referred to as a stimulation electrode combination. As described in further detail below, a stimulation electrode combination may be selected (e.g., based on the patient's condition) for a particular patient 112 and target tissue site. A set of electrodes 116, 118 includes at least one electrode and may include a plurality of electrodes. In some examples, the plurality of electrodes 116 and / or 118 may have a complex electrode geometry such that two or more electrodes are located at different locations around the periphery of the respective leads.

[0023] In some examples, the neural signals sensed within the brain 120 may reflect current changes generated by the sum of the potential differences throughout the brain tissue. Examples of neural brain signals include, but are not limited to, bioelectric signals generated by local field potentials (LFPs) sensed in one or more regions of the brain 120. Electroencephalogram (EEG) signals or electrocorticogram (ECoG) signals are also examples of bioelectric signals. For example, neurons generate bioelectric signals, and if measured at depth, the bioelectric signal is LFP, if measured on the dura mater, the bioelectric signal is ECoG, and if measured on the scalp, the bioelectric signal is EEG.

[0024] An example of a feature of interest (e.g., a biomarker) within an LFP is synchronized beta band (13 Hz-33 Hz) LFP activity recorded within the sensorimotor region of the subthalamic nucleus (STN) of a patient with Parkinson's disease. The source of the LFP activity can be considered to be a signal source within the patient's brain that outputs an oscillating voltage signal sensed by one or more of electrodes 116 and / or 118. Inhibition of pathological beta activity by both drugs and DBS (e.g., inhibiting or clearing signal components of the bioelectric signal generated by the LFP source in the beta band) can be associated with improvement in motor symptoms in patients with Parkinson's disease.

[0025] In some examples, the neural brain signals used to select the stimulation electrode combination may be sensed in the same area of ​​the brain 120 as the target tissue site for electrical stimulation. As previously noted, these tissue sites may include tissue sites within anatomical structures (such as the thalamus, subthalamic nucleus, or globus pallidus of the brain 120), as well as other target tissue sites. Specific target tissue sites and / or regions within the brain 120 may be selected based on the patient's condition. Therefore, in some examples, both the stimulation electrode combination and the sensing electrode combination may be selected from the same set of electrodes 116, 118. In other examples, the electrodes used to deliver electrical stimulation may be different from the electrodes used to sense the neural brain signals.

[0026] The electrical stimulation generated by the IMD 106 can be configured to manage various disorders and conditions. In some examples, the stimulation generator of the IMD 106 is configured to generate electrical stimulation pulses via electrodes of the selected stimulation electrode combination and deliver the electrical stimulation pulses to the patient 112. However, in other examples, the stimulation generator of the IMD 106 can be configured to generate and deliver continuous wave signals, such as sine waves or triangle waves. In either case, the stimulation generator within the IMD 106 can generate electrical stimulation treatment for DBS according to the selected treatment program. In the example of electrical stimulation in the form of stimulation pulses delivered by the IMD 106, the treatment program may include a set of treatment parameter values ​​(e.g., stimulation parameters), such as the stimulation electrode combination, pulse frequency, pulse width, and current or voltage amplitude of the pulse for delivering the stimulation to the patient 112. As previously noted, the electrode combination may indicate the specific electrodes 116, 118 selected for delivering the stimulation signal to the tissue of the patient 112, and the corresponding polarity of the selected electrodes.

[0027] In some examples, electrodes 116, 118 may be electrodes of a radially segmented DBS array (rDBSA). A radially segmented DBS array refers to electrodes that are segmented radially along the leads. As an example, leads 114A and 114B may include a first set of electrodes arranged circumferentially around leads 114A and 114B, all of which are at the same height level on leads 114A and 114B. Each electrode in the first set of electrodes is a separate segmented electrode and forms a level of electrodes of a radially segmented array. Leads 114A and 114B may include a second set of electrodes arranged circumferentially around leads 114A and 114B, all of which are at the same height level on leads 114A and 114B. Each electrode in the first set of electrodes is a separate segmented electrode and forms a level of electrodes of a radially segmented array. rDBSA electrodes may facilitate directional stimulation and sensing. Examples of such electrodes are shown in FIG. FIG. 4A to FIG. 4C Shown in.

[0028] Utilizing rDBSA electrodes, the IMD 106 may be configured to perform both directional stimulation and sensing, thereby enhancing the ability to target a source of LFP activity (also referred to as pathological neuronal activity). For example, utilizing rDBSA, the IMD 106 may be configured to perform directional sensing to determine the direction and / or orientation of an LFP source that generates a bioelectric signal having a signal component in the beta band. Techniques for determining the direction and / or orientation of an LFP source are described in more detail below. As an example, based on the determined direction and / or orientation, the IMD 106 may direct electrical stimulation toward the LFP source to suppress (e.g., eliminate) the signal component generated by the source in the beta band.

[0029] The signal component in the beta band is described as an example, and the technique is applicable to other types of LFP activity. In addition, the exemplary technique is not limited to examples where electrodes 116, 118 are rDBSA electrodes. The example using rDBSA electrodes is described as a way of directional stimulation and sensing. However, the exemplary technique can also be used in examples where directional stimulation and sensing are not available or are not used. In addition, there may be other ways to perform directional stimulation and sensing that do not require the use of rDBSA electrodes.

[0030] In order to suppress the signal component having the beta frequency band from the LFP source, the IMD 106 may output an electrical stimulation signal that changes the way the neurons of the LFP source generate signals. For example, the electrical stimulation directly inhibits a certain neuron population including the LFP source or excites a group of neurons that in turn inhibit another group of neurons (e.g., a network effect). The stimulation may act directly on the neurons, and not necessarily on the signals generated by the neurons (e.g., the LFP source).

[0031] As described in more detail, an algorithm may be used to determine the orientation of the LFP source relative to leads 114A and 114B, and the electrode of electrodes 116 and 118 that is closest to the LFP source. Typically, the electrode of electrodes 116 and 118 that is closest to the LFP source is often the electrode that is used to deliver electrical stimulation. The electrode of electrodes 116 and 118 that is closest to the LFP source may be the electrode with the highest current source density (CSD). For example, the electrode of electrodes 116 and 118 that has the highest CSD is also closest to the LFP source.

[0032] However, once it is determined which of electrodes 116 and 118 should be used to deliver therapy, the clinician may need to go through an extensive trial and error process to determine the correct amplitude or other therapy parameters. As described in more detail, the present invention describes exemplary techniques for combining a source direction and / or orientation algorithm (e.g., an algorithm for determining the direction and / or orientation of an LFP source) with adaptive stimulation to automatically select an optimal electrode combination and titrate the stimulation amplitude of the stimulation delivered via the electrode combination.

[0033] In this way, the clinician may not need to go through a lengthy trial-and-error process known as monopolar viewing to determine the electrode configuration and amplitude. In addition, even if the electrode configuration is known based on a determination of the direction and / or orientation of the LFP source (e.g., which electrodes of electrodes 116 and 118 to use), the clinician may need to go through a trial-and-error process to determine the correct stimulation amplitude. Using the exemplary techniques, a medical device (e.g., IMD 106 or possibly programmer 104) can automatically determine which electrodes to use and one or more treatment parameters (e.g., amplitude) of the electrical stimulation. Although the above examples are described with respect to amplitude, the exemplary techniques can be extended to other treatment parameters, such as frequency and pulse width of the electrical stimulation.

[0034] IMD 106 may be implanted in a subcutaneous pocket above the clavicle, or alternatively, on or in skull 122, or at any other suitable site in patient 112. Generally, IMD 106 is constructed of biocompatible materials that resist corrosion and degradation from body fluids. IMD 106 may include a hermetic housing to substantially enclose components, such as a processor, a therapy module, and a memory.

[0035] like Figure 1 As shown, implant lead extension 110 is coupled to IMD 106 via connector 108 (also referred to as a connector block or connector of IMD 106). Figure 1 In the example of FIG. 1 , lead extension 110 is passed from the implantation site of IMD 106 and along the neck of patient 112 to skull 122 of patient 112 to enter brain 120. Figure 1 In the example shown, leads 114A and 114B (collectively referred to as "leads 114") are implanted in the right and left hemispheres of patient 112, respectively (or in some examples, only one hemisphere) to deliver electrical stimulation to one or more regions of brain 120, which may be selected based on the patient's condition or disorder controlled by treatment system 100. However, a specific target tissue site and a stimulation electrode for delivering stimulation to the target tissue site may be selected, for example, based on identified patient behavior and / or other sensed patient parameters. For example, the target tissue site may be the location of an LFP source that generates a bioelectric signal having a signal component in the beta band. The stimulation electrodes for delivering stimulation to the target tissue site may be those stimulation electrodes that are closest to the LFP source, such as determined by the electrode with the highest CSD. Other leads 114 and IMD 106 implantation sites are contemplated. For example, in some examples, IMD 106 may be implanted on or in skull 122. In some examples, leads 114A and 114B may be implanted in the same hemisphere of the brain, or IMD 106 may be coupled to a single lead implanted in a single hemisphere of the brain.

[0036] Existing lead sets include axial leads carrying ring electrodes disposed at different axial positions and so-called "paddle" leads carrying planar array electrodes. The selection of electrode combinations within an axial lead, within a paddle lead, or between two or more different leads presents challenges to clinicians. In some examples, more complex lead array geometries may be used.

[0037] Although lead 114 is Figure 1 108. The leads 114 are shown as being coupled to a common lead extension 110, but in other examples, the leads 114 may be coupled to the IMD 106 via separate lead extensions or directly to the connector 108. The leads 114 may be positioned to deliver electrical stimulation to one or more target tissue sites within the brain 120 to manage patient symptoms associated with a movement disorder of the patient 112. The leads 114 may be implanted to position the electrodes 116, 118 at desired locations within the brain 120 through corresponding holes in the skull 122. The leads 114 may be placed at any location within the brain 120 so that the electrodes 116, 118 are able to provide electrical stimulation to target tissue sites within the brain 120 during treatment. For example, the electrodes 116, 118 may be surgically implanted beneath the dura mater of the brain 120 or within the cerebral cortex of the brain 120 via a burr hole in the skull 122 of the patient 112 and electrically coupled to the IMD 106 via one or more leads 114.

[0038] exist Figure 1 In the example shown, the electrodes 116, 118 of the lead 114 are shown as ring electrodes. Ring electrodes can be used in DBS applications because ring electrodes are relatively easy to program and can deliver electric fields to any tissue adjacent to the electrodes 116, 118. In other examples, the electrodes 116, 118 may have different configurations. For example, at least some of the electrodes 116, 118 of the lead 114 may have a complex electrode array geometry that is capable of generating a shaped electric field. The complex electrode array geometry may include multiple electrodes (e.g., partial rings or segmented electrodes) around the outer periphery of each lead 114, rather than a single ring electrode. In this way, electrical stimulation can be directed from the lead 114 in a specific direction to enhance the efficacy of the treatment and reduce possible adverse side effects caused by stimulating a large amount of tissue. For example, the electrodes 116, 118 may be electrodes of a radially segmented DBS array (rDBSA), as described above and as shown in FIG. FIG. 4A to FIG. 4C shown.

[0039] In some examples, the housing of IMD 106 may include one or more stimulation and / or sensing electrodes. In some examples, lead 114 may have a plurality of electrodes other than Figure 1For example, lead 114 may be a paddle lead, a ball lead, a bendable lead, or any other type of shape that is effective in treating patient 112 and / or minimizing the invasiveness of lead 114.

[0040] IMD 106 includes a memory for storing a plurality of treatment programs, each treatment program defining a set of treatment parameter values. In some examples, IMD 106 may select a treatment program from the memory based on various parameters, such as sensed patient parameters and identified patient behaviors. IMD 106 may generate electrical stimulation based on the parameters of the selected treatment program to manage patient symptoms associated with a movement disorder.

[0041] The external programmer 104 wirelessly communicates with the IMD 106 as needed to provide or retrieve treatment information. The programmer 104 is an external computing device that a user (e.g., a clinician and / or a patient 112) can use to communicate with the IMD 106. For example, the programmer 104 can be a clinician programmer that the clinician uses to communicate with the IMD 106 and program one or more treatment programs for the IMD 106. Alternatively, the programmer 104 can be a patient programmer that allows the patient 112 to select a program and / or view and modify treatment parameters. The clinician programmer may include more programming features than the patient programmer. In other words, only the clinician programmer may allow more complex or sensitive tasks to prevent untrained patients from making undesirable changes to the IMD 106.

[0042] When programmer 104 is configured for use by a clinician, programmer 104 may be used to transmit initial programming information to IMD 106. This initial information may include hardware information, such as the type and electrode arrangement of lead 114, the location of lead 114 within brain 120, the configuration of the array of electrodes 116, 118, an initial program defining therapy parameter values, and any other information that the clinician wishes to program into IMD 106. Programmer 104 may also be capable of completing functional tests (e.g., measuring the impedance of electrodes 116, 118 of lead 114).

[0043] The clinician may also store treatment programs in the IMD 106 with the aid of the programmer 104. During a programming session, the clinician may determine one or more treatment programs that may provide effective treatment to the patient 112 to address symptoms associated with the patient's condition, and in some cases, symptoms specific to one or more different patient states (such as a sleeping state, a moving state, or a resting state). For example, the clinician may select one or more stimulation electrode combinations with which stimulation is delivered to the brain 120. During a programming session, the clinician may evaluate the efficacy of a particular program based on feedback provided by the patient 112 or based on one or more physiological parameters of the patient 112 (e.g., muscle activity, muscle tension, stiffness, tremor, etc.). Alternatively, the identified patient behavior based on the video information may be used as feedback during the initial programming session and subsequent programming sessions. The programmer 104 may assist the clinician in creating / identifying treatment programs by providing a structured system for identifying potentially beneficial treatment parameter values.

[0044] However, as described in the present disclosure, in some examples, IMD 106 or programmer 104 (e.g., a medical device) may automatically determine electrode configurations and treatment parameters, alone or in combination. For example, a medical device may determine which electrodes to use for stimulation based on which electrodes are closest to a source of LFP. As described in more detail, the medical device may also titrate the amplitude of the stimulation or another parameter to automatically determine the stimulation amplitude. In some examples, programmer 104 may output information indicating the selected electrode configuration for stimulation and the determined stimulation amplitude or other treatment parameters for a clinician or physician to review and confirm before IMD 106 delivers treatment via the selected electrode configuration with the determined stimulation amplitude.

[0045] Programmer 104 may also be configured for use by patient 112. When configured as a patient programmer, programmer 104 may have limited functionality (compared to a clinician programmer) in order to prevent patient 112 from changing critical functions of IMD 106 or an application that may be harmful to patient 112. Thus, programmer 104 may only allow patient 112 to adjust values ​​of certain therapy parameters or set an available range of values ​​for a particular therapy parameter.

[0046] Programmer 104 may also provide indications to patient 112 when therapy is being delivered, when patient input has triggered a therapy change, or when a power source within programmer 104 or IMD 106 needs to be replaced or recharged. For example, programmer 104 may include an alert LED, may send messages to patient 112 via a programmer display, generate audible sounds, or physical cues to confirm receipt of patient input, such as to indicate patient status or to manually modify therapy parameters.

[0047] Therapy system 100 may be implemented to provide chronic stimulation therapy to patient 112 over the course of months or years. However, system 100 may also be employed on a trial basis to evaluate therapy prior to full implantation. If implemented temporarily, some components of system 100 may not be implanted in patient 112. For example, patient 112 may be provided with an external medical device, such as a trial stimulator, instead of IMD 106. The external medical device may be coupled to a percutaneous lead or implanted lead via a percutaneous extension. If the trial stimulator indicates that DBS system 100 is providing effective therapy to patient 112, the clinician may implant a chronic stimulator in patient 112 for relatively long-term therapy.

[0048] Although IMD 106 is described as delivering electrical stimulation therapy to brain 120, IMD 106 may be configured to direct electrical stimulation to other anatomical regions of patient 112. Additionally, an IMD may provide other electrical stimulation, such as spinal cord stimulation, to treat movement disorders.

[0049] According to the techniques of the present disclosure, a medical device (e.g., IMD 106 or programmer 104) of system 100 may be configured to determine treatment parameters for electrical stimulation delivered via electrodes 116, 118. In order to determine the treatment parameters, the medical device may first determine the orientation of the LFP source. An example of the orientation of the LFP source is to determine which of electrodes 116, 118 are closest to the LFP source. An example of the orientation of the LFP source is to determine the distance and / or position of the LFP source relative to electrodes 116, 118 or the position of the LFP source within the brain 120 inferred based on the electrode with the highest CSD, as described in more detail below.

[0050] There are various exemplary techniques for determining the orientation of the LFP source. As one example, IMD 106 may receive multiple records of bioelectric signals generated by the LFP source via electrodes 116, 118. The multiple records of bioelectric signals may be multiple voltage measurements of the bioelectric signals. IMD 106 may bandpass filter the multiple records of bioelectric signals to generate multiple filtered signals, where each filtered signal is from each electrode in electrodes 116, 118. For example, IMD 106 may generate a first filtered signal based on the output of a first electrode in electrodes 116 that senses the bioelectric signal generated by the LFP source, generate a second filtered signal for a second electrode in electrodes 116, and so on.

[0051] Based on each of the filtered signals, the IMD 106 may determine a current source density (CSD) value for each corresponding electrode 116, 118. For example, all signals from all electrodes 116, 118 may be used to calculate the CSD value. A single CSD value for a given electrode may require a signal sensed by the electrode and from an adjacent electrode. The CSD value of an electrode is a measure of the net current across the electrode. The IMD 106 may determine which of the electrodes 116, 118 have the highest CSD value. The electrodes 116, 118 with the highest CSD values ​​tend to be the electrodes closest to the LFP source, and also tend to be the electrodes (or adjacent electrodes) used to deliver electrical stimulation therapy. Therefore, the CSD value can be used to infer the proximity of the electrode to the LFP source.

[0052] An exemplary manner of determining the CSD of a corresponding electrode is to determine it based on the voltage difference of adjacent electrodes. For example, IMD 106 may determine the CSD value based on the voltage difference between adjacent electrodes. In some examples, the CSD value may be a second spatial difference of the voltage difference along the electrode. Each second spatial difference in the second spatial difference of the voltage difference may be a difference between the voltage difference. In other words, in some examples, the CSD value may be a difference between the voltage difference along the lead. In a more specific example, two CSD values ​​for a four-electrode system will be (V1-V2)-(V2-V3) and (V2-V3)-(V3-V4).

[0053] IMD 106 may determine a CSD value for each electrode located between two other electrodes. Generally, in a system including N electrodes, IMD 106 may determine N-2 CSD values, each of which may be associated with a different one of the electrodes. In some examples, end electrodes (e.g., electrodes that are not disposed between two adjacent electrodes) may not have an associated CSD value because the outer electrodes may not be associated with two different voltage difference values.

[0054] There may be other ways to determine the orientation or direction of the LFP source (e.g., based on the proximity of the electrodes), and the exemplary techniques for determining the orientation of the LFP source should not be considered limiting. There may also be other ways to determine CSD values, and the exemplary techniques for determining CSD values ​​should not be considered limiting. Exemplary techniques for determining the orientation of the LFP source are described in U.S. Patent Publication No. 2017 / 0259064 and U.S. Patent Publication No. 2014 / 0074187.

[0055] Once the electrodes for delivering electrical stimulation are selected, the clinician or patient may need to spend time on a trial and error approach to determine the treatment parameters. In addition, sometimes adjustments to the treatment parameters do not provide any further beneficial effects to the patient, but the clinician may not be able to determine that further adjustments will not provide a beneficial effect to the patient.

[0056] For example, in response to the delivery of a current electrical stimulation having a current treatment parameter value (e.g., using electrodes 116, 118 selected based on the CSD value), IMD 106 may determine a current power value for power in a frequency band (e.g., a beta band) in the bioelectric signal generated by the LFP source and sensed by the sensing electrodes. It is also assumed that, prior to determining the current power, IMD 106 has determined a previous power value for power in the frequency band in response to the delivery of a previous electrical stimulation having a previous treatment value that was different from the current treatment parameter value. In some cases, if the difference between the current power value and the previous power value is less than a threshold value (e.g., as a non-limiting example, ), further adjustment of the treatment value may not provide significantly more effective treatment. In other words, if the Δ (e.g., difference) between the current power value and the previous power value is less than the threshold, then adjusting the treatment value may not have any further beneficial effect.

[0057] However, the clinician or patient may not be able to determine the power value, let alone determine whether the difference between the current power value and the previous power value is less than or greater than the threshold value. Therefore, even if it is feasible to stop adjusting the treatment value earlier, the clinician may continue to adjust the treatment value until the patient feels side effects.

[0058] The present disclosure describes an exemplary technique for automatically determining a treatment value based on the difference between a current power value of power in a frequency band (e.g., a beta band) of a current bioelectric signal and a previous power value of power in a frequency band of a previous bioelectric signal. For example, if the difference is greater than a threshold, the medical device may iteratively adjust the current treatment parameter value and deliver electrical stimulation with the adjusted parameter value until the difference between the current power value (e.g., the power value of the power in the frequency band in the current iteration) and the previous power value (e.g., the power value of the power in the frequency band in the previous iteration) is less than the threshold. Once the difference becomes less than the threshold, the medical device may stop adjusting the current treatment parameter value and set the final treatment parameter value to be equal to the current treatment parameter value. The medical device may cause electrical stimulation with the final treatment parameter value to be delivered.

[0059] For example, as described above, the brain 120 includes an LFP source that generates a bioelectric signal. The power of the bioelectric signal in a frequency band (e.g., a beta band) may be based on a therapeutic parameter value of a therapeutic parameter in the electrical stimulation delivered by the IMD 106 via electrodes 116, 118. For example, for a certain therapeutic parameter value, the electrical stimulation may suppress the beta band of the bioelectric signal (e.g., so that the power of the beta band is relatively low), which often reduces the symptoms of certain diseases such as Parkinson's disease. The current power level indicates the current power of the frequency band of the bioelectric signal generated in response to the current electrical stimulation, and the previous power level indicates the previous power of the frequency band of the bioelectric signal in response to the previous electrical stimulation. A decrease in the difference between the current power level and the previous power level may indicate suppression of the beta band, and when there is no further change between the current power level and the previous power level (e.g., the difference is less than a threshold), then further adjustment of the therapeutic parameter may not result in any further suppression of the beta band in the bioelectric signal.

[0060] In this way, the exemplary technology can automatically titrate the treatment parameter value based on whether the difference between the current power value and the previous power value is greater than a threshold value. Compared with a manual trial and error process, the medical device can determine the treatment parameter value more quickly without the involvement of a clinician or patient. In addition, when the difference between the current power value and the previous power value is less than the threshold value, the medical device can stop adjusting the treatment parameter value, which can reduce the amount of treatment parameter values ​​that need to be tested to determine the final treatment parameter value.

[0061] Figure 2 is used to deliver adaptive deep brain stimulation therapy Figure 1 A block diagram of an exemplary IMD 106 is shown. Figure 2 In the example shown, IMD 106 includes processing circuit 210, memory 211, stimulation generation circuit 202, sensing circuit 204, switch circuit 206, telemetry circuit 208, and power supply 220. Each of these circuits may be or include circuits configured to perform the functions attributed to each respective circuit. Memory 211 may include any volatile or non-volatile media, such as random access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically erasable programmable ROM (EEPROM), flash memory, etc. Memory 211 may store computer-readable instructions that, when executed by processing circuit 210, cause IMD 106 to perform various functions. Memory 211 may be a storage device or other non-transitory medium.

[0062] exist Figure 2In the example shown, the memory 211 stores the treatment programs 214, the previous power values ​​216, and the sensing electrode combinations and the associated stimulation electrode combinations 218 in a separate memory within the memory 211 or in a separate area within the memory 211. Each stored treatment program 214 defines a specific set of electrical stimulation parameters (e.g., a treatment parameter set), such as stimulation electrode combinations, electrode polarity, current or voltage amplitude, pulse width, and pulse frequency. In some examples, the individual treatment programs can be stored as a treatment group that defines a group of treatment programs that can be used to generate stimulation. The stimulation signals defined by the treatment programs of the treatment group can be delivered together on an overlapping or non-overlapping (e.g., time-interleaved) basis.

[0063] Previous power value 216 indicates a power level in a frequency band of a bioelectric signal generated in response to delivery of a previous electrical stimulation having a previous therapy parameter value that was different from the current therapy parameter value. As described in more detail, in some examples, as a way to automatically titrate the therapy parameter to an appropriate value, IMD 106 may determine a difference between previous power value 216 and the current power value to determine whether further adjustment of the therapy parameter value is needed.

[0064] The sensing and stimulation electrode combination 218 stores sensing electrode combinations and associated stimulation electrode combinations. As described above, in some examples, the sensing and stimulation electrode combination 218 may include the same subset of electrodes 116, 118, the housing of the IMD 106 used as electrodes, or may include different subsets or combinations of such electrodes. Therefore, the memory 211 may store multiple sensing electrode combinations, and for each sensing electrode combination, store information identifying the stimulation electrode combination associated with the corresponding sensing electrode combination. The association between the sensing electrode combination and the stimulation electrode combination may be determined, for example, by a clinician or automatically by the processing circuit 210. In some examples, the corresponding sensing electrode combination and the stimulation electrode combination may include some or all of the same electrodes. However, in other examples, some or all of the electrodes in the corresponding sensing electrode combination and the stimulation electrode combination may be different. For example, the stimulation electrode combination may include more electrodes than the corresponding sensing electrode combination in order to increase the efficacy of the stimulation therapy.

[0065] Under the control of the processing circuit 210, the stimulation generation circuit 202 generates stimulation signals for delivery to the patient 112 via the selected combination of electrodes 116, 118. An example range of electrical stimulation parameters believed to be effective in managing a patient's movement disorders in DBS includes:

[0066] 1. Pulse frequency, ie, frequency: between about 40 Hz and about 500 Hz, such as between about 90 Hz and 170 Hz or such as about 90 Hz.

[0067] 2. For a voltage control system, voltage amplitude: between about 0.1 volts and about 50 volts, such as between about 2 volts and about 3 volts.

[0068] 3. For a current control system, current amplitude: between about 1 mA and about 3.5 mA, such as between about 1.0 mA and about 1.75 mA.

[0069] 4. Pulse width: between about 50 microseconds and about 500 microseconds, such as between about 50 microseconds and about 200 microseconds.

[0070] Thus, in some examples, the stimulation generation circuit 202 generates an electrical stimulation signal according to the above-described electrical stimulation parameters. Other ranges of treatment parameter values ​​may also be useful and may depend on the target stimulation site in the patient 112. Although stimulation pulses are described, the stimulation signal may be in any form, such as a continuous time signal (e.g., a sine wave), etc.

[0071] Processing circuitry 210 may include fixed function processing circuitry and / or programmable processing circuitry, and may include, for example, one or more of the following: a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA), discrete logic circuitry, or any other processing circuitry configured to provide the functionality attributed to processing circuitry 210, which may be embodied herein as firmware, hardware, software, or any combination thereof. Processing circuitry 210 may control stimulation generation circuitry 202 in accordance with therapy programs 214 stored in memory 211 to apply specific stimulation parameter values, such as voltage amplitude or current amplitude, pulse width, and / or pulse frequency, specified by one or more of the programs.

[0072] exist Figure 2In the example shown, the group of electrodes 116 includes electrodes 116A, 116B, 116C, and 116D, and the group of electrodes 118 includes electrodes 118A, 118B, 118C, and 118D. The processing circuit 210 also controls the switching circuit 206 to apply the stimulation signal generated by the stimulation generation circuit 202 to the selected combination of electrodes 116, 118. Specifically, the switching circuit 206 can couple the stimulation signal to the selected conductor within the lead 114, and then deliver the stimulation signal through the selected electrodes 116, 118. The switching circuit 206 can be a switch array, a switch matrix, a multiplexer, or any other type of switch module configured to selectively couple stimulation energy to the selected electrodes 116, 118 and selectively sense neural brain signals using the selected electrodes 116, 118. Therefore, the stimulation generation circuit 202 is connected to the electrodes 116, 118 via the switching circuit 206 and the conductors within the lead 114. However, in some examples, IMD 106 does not include switching circuit 206 .

[0073] The stimulation generation circuit 202 may be a single-channel or multi-channel stimulation generator. Specifically, the stimulation generation circuit 202 may be capable of delivering a single stimulation pulse, multiple stimulation pulses, or a continuous signal at a given time via a single electrode combination, or delivering multiple stimulation pulses at a given time via multiple electrode combinations. However, in some examples, the stimulation generation circuit 202 and the switch circuit 206 may be configured to deliver multiple channels on a time-interleaved basis. For example, the switch circuit 206 may be used to time-divide the output of the stimulation generation circuit 202 on different electrode combinations at different times to deliver multiple programs or channels of stimulation energy to the patient 112. Alternatively, the stimulation generation circuit 202 may include multiple voltage or current sources and receivers that are connected to corresponding electrodes to drive the electrodes as cathodes or anodes. In this example, the IMD 106 may not require the time-interleaved multiplexing function of the switch circuit 206 for stimulation via different electrodes.

[0074] The electrodes 116, 118 on the respective leads 114 may be constructed of a variety of different designs. For example, one or more of the leads 114 may include two or more electrodes at each longitudinal position along the length of the lead, such as at each of positions A, B, C, and D, multiple electrodes at different peripheral positions around the perimeter of the lead, for example, arranged in segments. FIG. 4A to FIG. 4C Such exemplary leads are shown.

[0075] For example, one or more of leads 114 may include electrodes of a radially segmented DBS array (rDBSA). In an rDBSA, as an example, there may be a first ring electrode of electrode 116 around the perimeter of lead 114A at a first longitudinal position on lead 114A (e.g., position A). Below the first ring electrode, there may be three segment electrodes of electrode 116 around the perimeter of lead 114A at a second longitudinal position on lead 114A (e.g., position B). Below these three segment electrodes, there may be another set of three segment electrodes of electrode 116 around the perimeter of lead 114A at a third longitudinal position of lead 114A (e.g., position C). Below these three segment electrodes, there may be a second ring electrode of electrode 116 around the perimeter of lead 114A (e.g., position D). Electrode 118 may be similarly positioned along lead 114B.

[0076] The above is one example of an electrode of a rDBSA array, and the exemplary technology should not be considered limited to such an example. There may be other configurations of electrodes for DBS. Furthermore, the exemplary technology is not limited to DBS, and other electrode configurations are also possible.

[0077] In one example, the electrodes 116, 118 can be electrically coupled to the switch circuit 206 via corresponding wires that are straight or coiled within the housing of the lead and extend to a connector at the proximal end of the lead. In another example, each of the electrodes 116, 118 of the lead 114 can be an electrode deposited on a film. The film may include a conductive trace for each electrode that extends along the length of the film to the proximal end connector. The film can then be wrapped (e.g., spirally wrapped) around the internal member to form the lead 114. These and other configurations can be used to form leads with complex electrode geometries.

[0078] Although the sensing circuit 204 Figure 2 In one embodiment, the sensing circuit 204 is incorporated into a common housing with the stimulation generating circuit 202 and the processing circuit 210, but in other examples, the sensing circuit 204 may be located in a housing separate from the IMD 106 and may communicate with the processing circuit 210 via wired or wireless communication techniques. Exemplary neural brain signals include, but are not limited to, signals generated by local field potentials (LFPs) within one or more regions of the brain 28. EEG and ECoG signals are examples of local field potentials that can be measured within the brain 120. LFP, EEG, and ECoG may be different measurements of the same bioelectric signal in the brain. Neurons generate signals, and if measured deep, the signal is an LFP, if measured on the dura, the signal is an ECoG, and if measured on the scalp, the signal is an EEG.

[0079] Under the control of the processing circuit 210, the telemetry circuit 208 supports wireless communication between the IMD 106 and the external programmer 104 or another computing device. As an update to the program, the processing circuit 210 of the IMD 106 can receive values ​​of various stimulation parameters such as magnitude and electrode combinations from the programmer 104 via the telemetry circuit 208. Updates to the treatment program can be stored in the treatment program 214 portion of the memory 211. The telemetry circuit 208 in the IMD 106 and the telemetry modules in other devices and systems described herein (such as, the programmer 104) can communicate through radio frequency (RF) communication technology. In addition, the telemetry circuit 208 can communicate with the external medical device programmer 104 via the proximal sensing interaction of the IMD 106 with the programmer 104. Therefore, the telemetry circuit 208 can send information to the external programmer 104 continuously, at periodic intervals, or based on a request from the IMD 106 or the programmer 104.

[0080] Power source 220 delivers operating power to the various components of IMD 106. Power source 220 may include a small rechargeable battery or a non-rechargeable battery and a power generation circuit to generate operating power. Recharging may be accomplished through proximal inductive interaction between an external charger and an inductive charging coil within IMD 104. In some examples, the power requirements may be small enough to allow IMD 104 to take advantage of patient motion and implement a kinetic energy scavenging device to trickle charge the rechargeable battery. In other examples, conventional batteries may be used for a limited period of time.

[0081] In one example, the processing circuit 210 of the IMD 106 senses one or more bioelectric signals of the brain 120 of the patient 112 via the electrodes 116, 118 (and the sensing circuit 204) inserted along the lead 114. In addition, the processing circuit 210 of the IMD 106 delivers electrical stimulation therapy to the patient 112 via the electrodes 116, 118 (and the stimulation generation circuit 202) based on the sensed one or more bioelectric signals of the brain 120. The adaptive DBS therapy is defined by one or more therapy programs 214 having one or more parameters stored in the memory 211. For example, the one or more parameters include current amplitude (for current control systems) or voltage amplitude (for voltage control systems), pulse frequency or frequency, and pulse width, or the number of pulses per cycle. In the example of delivering electrical stimulation according to a "burst" of pulses or a series of electrical pulses defined by an "on time" and an "off time", the one or more parameters may also define one or more of the number of pulses per burst, the on time, and the off time. Processing circuitry 210 delivers adaptive DBS to patient 112 via electrodes 116 , 118 , and may adjust one or more parameters defining electrical stimulation based on corresponding parameters of the sensed one or more bioelectric signals of brain 120 .

[0082] In some examples, the processing circuit 210 continuously measures the one or more bioelectric signals in real time. In other examples, the processing circuit 210 periodically samples the one or more bioelectric signals according to a predetermined frequency or after a predetermined amount of time. In some examples, the processing circuit 210 periodically samples the signals at a frequency of approximately 150 Hz.

[0083] According to the techniques of the present disclosure, the processing circuit 210 may be configured to determine which electrodes 116, 118 should be used to deliver electrical stimulation (e.g., based on the orientation of the LFP source), and to determine the therapeutic parameter value of the therapeutic parameter of the electrical stimulation. To determine which electrodes 116, 118 are used to deliver electrical stimulation, the processing circuit 210 may determine which electrodes 116, 118 have the maximum current source density (CSD) value due to sensing the LFP signal from the LFP source. However, other techniques for determining which electrodes 116, 118 are used to deliver electrical stimulation are also possible.

[0084] As an exemplary way of determining the CSD value, the processing circuit 210 may cause the sensing circuit 204 to measure the voltage across the electrode pair (e.g., electrodes 116, 118), where the voltage across the electrode pair (e.g., electrodes 116, 118) is due to the bioelectric signal generated by the LFP source. The result of the measured voltage can be a set of differential voltages. The processing circuit 210 can then determine the difference between the differential voltages in the set of differential voltages to determine the CSD value of one or more electrodes (top and bottom electrodes may be desired) of the electrodes 116, 118. The processing circuit 210 can compare the CSD values ​​of the electrodes 116, 118 to determine which electrode(s) of the electrodes 116, 118 have the largest CSD value. The electrodes 116, 118 with the largest CSD values ​​tend to be the electrodes closest to the LFP source and used to deliver stimulation.

[0085] In this way, the processing circuit 210 can determine which electrodes are closest to the signal source (e.g., LFP source) that generates the bioelectric signal or have the highest CSD value. The processing circuit 210 can select the determined electrode closest to the signal source (e.g., LFP source) for delivering electrical stimulation. The processing circuit 210 can cause the stimulation generation circuit 202 and / or the switch circuit 206 to deliver electrical stimulation using the selected electrode.

[0086] In addition to determining which electrodes are used to deliver electrical stimulation, in some examples, processing circuit 210 can be configured to determine a therapeutic parameter value for a therapeutic parameter of the electrical stimulation. For ease of description, the following is described with respect to determining the amplitude (e.g., voltage amplitude and / or current amplitude) of the electrical stimulation. The exemplary techniques can be applied to other electrical stimulation parameters, such as pulse width and frequency.

[0087] The processing circuit 210 may deploy an exemplary adaptive stimulation protocol described in the present disclosure on the selected electrodes 116, 118 (selected in the manner described above) to titrate stimulation for suppressing beta power (e.g., suppressing beta band components in the bioelectric signal). The exemplary protocol utilized by the processing circuit 210 is referred to as "ping and listening," in which the amplitude of the electrical stimulation is gradually increased based on the suppression of beta band power, which is derived from the simultaneous sensing of the voltage generated from the LFP source (e.g., simultaneous LFP recording).

[0088] For example, as described in more detail, the processing circuit 210 may utilize voltage measurements from the LFP source in response to an increase in the amplitude of the electrical stimulation to determine whether the delivery of the electrical stimulation effectively suppresses the beta band power. In some examples, the sensing circuit 204 may output to the processing circuit 210 a differential voltage between two electrodes adjacent to the electrode selected for delivering the electrical stimulation. Thus, the processing circuit 210 may receive information about the sensed bioelectric signal from one or more electrodes adjacent to one of the electrodes selected for delivering the electrical stimulation. The processing circuit 210 may be configured to determine a power value of power in a frequency band (e.g., a beta band) based on the received information. Exemplary techniques for determining a power value of power in a frequency band are described in more detail below.

[0089] One exemplary reason for determining the power value of the power in the frequency band based on the bioelectric signal sensed by the electrode adjacent to the stimulation electrode (e.g., the electrode immediately adjacent to the stimulation electrode) is that the impedance of the adjacent electrode and the stimulation electrode may be approximately the same, which may minimize stimulation artifacts in the bioelectric signal. Although this example describes the use of an electrode adjacent to the stimulation electrode to sense the bioelectric signal generated in response to the delivery of electrical stimulation, the exemplary technology is not limited thereto. In addition to or in place of the adjacent electrode, other electrodes may be used to sense the bioelectric signal generated in response to the delivery of electrical stimulation.

[0090] To determine the therapeutic parameter value for the therapeutic parameter, the processing circuit 210 may determine whether the delivery of the electrical stimulation causes a sufficient difference (e.g., less than a threshold) in power in a frequency band (e.g., a beta band). If the difference is greater than or equal to the threshold, the processing circuit 210 may continue to adjust the therapeutic parameter. However, if the difference is less than the threshold, the processing circuit 210 may stop adjusting the therapeutic parameter.

[0091] For example, processing circuit 210 may determine a current power value of power in a frequency band in a bioelectric signal generated in brain 120 in response to delivery of a current electrical stimulation having a current treatment parameter value. Processing circuit 210 may determine a power band difference between the current power value and a previous power value. The previous power value indicates power in a frequency band in a previous bioelectric signal generated in brain 120 in response to delivery of a previous electrical stimulation having a previous treatment parameter value different from the current treatment parameter value. An example of a previous power value is previous power value 216 stored in memory 211.

[0092] Processing circuit 210 may compare the power band difference value to a threshold value. Based on the power band difference value being greater than or equal to the threshold value, processing circuit 210 may iteratively adjust the current therapy parameter value until the power band difference value is less than the threshold value. Processing circuit 210 may then set the final therapy parameter value equal to the current therapy parameter value and cause (e.g., via stimulation generation circuit 202 and / or switch circuit 206) electrical stimulation with the final therapy parameter value to be delivered.

[0093] For example, assume that the first group of electrodes 116 are selected as stimulation electrodes (e.g., based on the highest CSD value). Additionally, assume that the second group of electrodes 116 are adjacent to the first group of electrodes. The processing circuit 210 may set the treatment parameter value of the amplitude treatment parameter to a first value (which will later be a previous value), and cause the stimulation generation circuit 202 and / or the switch circuit 206 to deliver electrical stimulation via the first group of electrodes, wherein the amplitude is set by the first value. The second group of electrodes senses the bioelectric signal, and the sensing circuit 204 outputs the sensed bioelectric signal to the processing circuit 210. The processing circuit 210 then determines a power value for the power in a frequency band (e.g., a beta band), and stores the determined power value as the previous power value 216.

[0094] The processing circuit 210 may then adjust (e.g., increase or decrease) the treatment parameter value to a second value (which is now the current value) and cause the stimulation generation circuit 202 and / or the switch circuit 206 to deliver electrical stimulation via the first set of electrodes, wherein the amplitude is set by the second value. The second set of electrodes senses the bioelectric signal, and the sensing circuit 204 outputs the sensed bioelectric signal to the processing circuit 210. The processing circuit 210 then determines a power value for the power in a frequency band (e.g., a beta band), which is the current power value.

[0095] The processing circuit 210 may determine a power band difference between the current power value and the previous power value 216, and compare the power band difference to a threshold value (e.g., a predefined or preconfigured threshold value stored in the memory 211). If the power band difference is less than the threshold value, the processing circuit 210 may set the final treatment parameter value equal to the current treatment parameter value.

[0096] However, if the power band difference is greater than or equal to the threshold, the processing circuit 210 may iteratively adjust the current treatment parameter value until the power band difference is less than the threshold. For example, the processing circuit 210 may set the previous power value 216 to be equal to the current power value. The processing circuit 210 may then adjust the value of the current treatment parameter value to the new current treatment parameter value. The stimulation generation circuit 202 and / or the switch circuit 206 may then deliver electrical stimulation having an amplitude equal to the new current treatment parameter value. The processing circuit 210 may receive information of the sensed bioelectric signal from the second set of electrodes, and may determine whether the difference between the current power value (e.g., the new current treatment parameter value) and the previous power value 216 is less than, greater than, or equal to the threshold.

[0097] The processing circuit 210 may continue to iterate the treatment parameter value until the difference between the current power value and the previous power value is less than a threshold value. In this way, the processing circuit 210 may iterate the treatment parameter value in a "detect and listen" manner (e.g., where detection is the delivery of electrical stimulation and listening is the sensing of bioelectric signals) until the processing circuit 210 determines a treatment parameter value where the difference in power in a frequency band (e.g., a beta band) in the bioelectric signal does not change by more than a threshold value.

[0098] In the above examples, processing circuit 210 is described as determining a power value for power in a frequency band. The following describes an exemplary manner in which processing circuit 210 may determine power in a frequency band. However, the exemplary techniques should not be considered limited to exemplary techniques for determining a power value for power in a frequency band.

[0099] The stimulation generation circuit 202 and / or the switching circuit 206 delivers electrical stimulation in a time period t(s), during which a treatment parameter value of a treatment parameter (e.g., amplitude) is kept constant starting from a minimum treatment parameter value. The sensing circuit 204 may wait and allow the stimulation to stabilize in a first portion of the time period (e.g., a first half-time period), and the processing circuit 210 may calculate a power value of the power in the frequency band in a second portion of the time period (e.g., a second half-time period) based on information of the sensed bioelectric signal output by the sensing circuit 204. An exemplary manner of determining the power value of the power in the frequency band is by calculating the average value of the power in a series of w(s) moving windows with w / 2(s) overlap.

[0100] For example, the processing circuit 210 may cause the stimulation generation circuit 202 and / or the switching circuit 206 to deliver electrical stimulation with a current therapeutic parameter value during a first time period of t seconds (e.g., a t(s) period). To determine the current power value of the power in the frequency band, the processing circuit 210 may determine a series of power level values ​​(e.g., determine the power level values ​​in the w(s) window) starting from a first portion of the first time period of t seconds during the delivery of the current electrical stimulation with the current therapeutic parameter value for the first time period of t seconds. The first portion may be after the start of the first time period (e.g., a midpoint of the first time period). The processing circuit 210 may determine the current power value of the power in the frequency band based on the series of power level values ​​(e.g., an average of the power level values ​​in the w(s) window).

[0101] As described above, in one example, there is w / 2(s) overlap in the w(s) window. Thus, processing circuitry 210 may begin determining the series of power values ​​at a midpoint in delivering therapy (e.g., which lasts t seconds). Processing circuitry 210 may then continue determining the series of power values ​​even after delivery of therapy is stopped, such that the amount of time that processing circuitry 210 delivers the series of power level values ​​is equal to a second time period. In some examples, the first time period and the second time period may be the same.

[0102] For example, to aid understanding and not to be considered limiting, assume that processing circuit 210 causes stimulus generation circuit 202 and / or switch circuit 206 to deliver electrical stimulation within 500 ms (e.g., t seconds of the t(s) period is 500 ms). During the 500 ms, processing circuit 210 may maintain the amplitude of the electrical stimulation constant. At the first portion of t seconds, after the first time period of 500 ms begins, processing circuit 210 may begin determining the series of power level values. As an example, at the midpoint (e.g., after 250 ms), processing circuit 210 may begin determining the series of power level values.

[0103] After an additional 250 ms, the stimulation generation circuit 202 and / or the switch circuit 206 may have stopped delivering the electrical stimulation (e.g., as described above, in this example, the duration of the time period for delivering therapy is 500 ms). In some examples, the processing circuit 210 may continue to determine the series of power level values ​​even after the stimulation generation circuit 202 and / or the switch circuit 206 have stopped delivering the electrical stimulation. For example, the processing circuit 210 may determine that the series of power level values ​​lasts for a second time period. In some examples, the second time period may be different from the first time period, where the first time period is when the stimulation generation circuit 202 and / or the switch circuit 206 delivers the electrical stimulation. In some examples, the second time period may be the same as the first time period, where the first time period is when the stimulation generation circuit 202 and / or the switch circuit 206 delivers the electrical stimulation.

[0104] For example, if the first time period during which the stimulus generation circuit 202 and / or the switch circuit 206 delivers the electrical stimulus is equal to 500 ms, and the processing circuit 210 begins determining the series of power levels starting at the midpoint of 250 ms, then, in one example, the processing circuit 210 may continue determining the series of power level values ​​for 500 ms (e.g., 250 ms after the stimulus generation circuit 202 and / or the switch circuit 206 delivers the electrical stimulus and stops delivering the stimulus). In this example, the t(s) time period (e.g., the first time period) is 500 ms. The w(s) time period (e.g., the second time period) is also equal to 500 ms. In addition, because the processing circuit 210 begins determining the series of power level values ​​starting at the midpoint and extending beyond the time during which the electrical stimulus is delivered, there is a w / 2(s) time period that overlaps the time during which the electrical stimulus is delivered and the time during which the processing circuit 210 determines the series of power level values.

[0105] In the above example, processing circuit 210 may stop adjusting the treatment parameter value until the difference between the current power value and the previous power value is less than a threshold value. In some examples, if the patient experiences any side effects during the adjustment of the treatment parameter value, the patient may be able to stop adjusting the treatment parameter value. Therefore, at the end of the stimulation time period, processing circuit 210 may calculate the absolute difference between the current power value and the previous power value, and collect any patient feedback about adverse side effects. Based on the absolute difference in power values ​​(and in some examples, based on patient feedback), processing circuit 210 may adjust the treatment parameter value until processing circuit 210 determines the final treatment parameter value for delivering electrical stimulation.

[0106] One example of a scheme that the processing circuit 210 can use to determine the treatment parameter value is given by the following pseudo code. The variables in the pseudo code are as follows: Amin is the minimum stimulation amplitude but is updated at each iteration, Amax is the maximum stimulation amplitude, A is the current stimulation amplitude (e.g., the current treatment parameter value), SE is the side effect state, "threshold" is the tolerance for the frequency band difference value (e.g., the beta band), Pcurr is the current power value, and Pprev is the previous power value,

[0107] At the same time (ΔP ≥ threshold and SE = No)

[0108] A = Amin + ((Amax - Amin) / 2);

[0109] Stimulate with amplitude A and sense bioelectric signals (e.g., record LFP);

[0110] Collect patient feedback on side effects;

[0111] If (SE=Yes)

[0112] Amax=A;

[0113] Otherwise (SE = No)

[0114] Amin=A;

[0115] Determine ΔP = absolute value (Pcurr-Pprev)

[0116] Finish

[0117] In the above example, the processing circuit 210 may iteratively set the previous treatment parameter value (e.g., Amin) to be equal to the current treatment parameter value (e.g., A). For example, in the above pseudocode, the processing circuit 210 may set Amin=A. The processing circuit 210 may also iteratively adjust the current treatment parameter value to a new current treatment parameter value. In the above pseudocode, in order to adjust the current treatment parameter value, the processing circuit 210 may set A=Amin+((Amax-Amin) / 2). Setting A=Amin+((Amax-Amin) / 2) may be considered as the processing circuit 210 applying a binary search algorithm, where Amin is the previous treatment parameter value. However, other types of algorithms (e.g., instead of or in addition to the binary search algorithm) are also possible. In the above example, the processing circuit 210 may iteratively set the previous treatment parameter value to be equal to the current treatment parameter value, and adjust the current treatment parameter value until the power difference value drops below a tolerance value (e.g., a threshold) and no side effects are reported.

[0118] Figure 3 yes Figure 11 is a block diagram of an external programmer 104. Although programmer 104 may generally be described as a handheld device, programmer 104 may be a larger portable device or a more fixed device. Furthermore, in other examples, programmer 104 may be included as part of an external charging device or include the functionality of an external charging device. Figure 3 As shown, programmer 104 may include processing circuitry 310, memory 311, user interface 302, telemetry circuitry 308, and power supply 320. Memory 311 may store instructions that, when executed by processing circuitry 310, cause processing circuitry 310 and external programmer 104 to provide functionality attributed to external programmer 104 throughout this disclosure. Each of these components or modules may include circuitry configured to perform some or all of the functions described herein. For example, processing circuitry 310 may include processing circuitry configured to perform the processes discussed with respect to processing circuitry 310.

[0119] In general, programmer 104 includes any suitable hardware arrangement, alone or in combination with software and / or firmware, to perform the techniques attributed to programmer 104 and processing circuitry 310, user interface 302, and telemetry circuitry 308 of programmer 104. In various examples, programmer 104 may include one or more processors, which may include fixed-function processing circuitry and / or programmable processing circuitry, such as formed by, for example, one or more microprocessors, DSPs, ASICs, FPGAs, or any other equivalent integrated or discrete logic circuitry, and any combination of such components. In various examples, programmer 104 may also include memory 311 (such as, RAM, ROM, PROM, EPROM, EEPROM, flash memory, hard disk, CD-ROM) that includes executable instructions for causing the one or more processors to perform the actions attributed to them. In addition, although processing circuitry 310 and telemetry circuitry 308 are described as separate modules, in some examples, processing circuitry 310 and telemetry circuitry 308 may be functionally integrated with each other. In some examples, processing circuit 310 and telemetry circuit 308 correspond to respective hardware units, such as an ASIC, DSP, FPGA, or other hardware units.

[0120] Memory 311 (e.g., a storage device) may store instructions that, when executed by processing circuit 310, cause processing circuit 310 and programmer 104 to provide the functionality attributed to programmer 104 throughout this disclosure. For example, memory 311 may include instructions that cause processing circuit 310 to retrieve a parameter set from memory or receive user input and send a corresponding command to IMD 106, or instructions for any other functionality. Furthermore, memory 311 may include a plurality of programs, where each program includes a parameter set that defines a stimulation therapy.

[0121] The user interface 302 may include buttons or a keypad, lights, a speaker for voice commands, a display such as a liquid crystal (LCD), a light emitting diode (LED), or an organic light emitting diode (OLED). In some examples, the display may be a touch screen. The user interface 302 may be configured to display any information related to the delivery of the stimulation therapy, the identified patient behavior, the sensed patient parameter values, the patient behavior criteria, or any other such information. The user interface 302 may also receive user input via the user interface 302. The input may be in the form of, for example, pressing a button on a keypad or selecting an icon from a touch screen.

[0122] Under the control of processing circuitry 310, telemetry circuitry 308 may support wireless communication between IMD 106 and programmer 104. Telemetry circuitry 308 may also be configured to communicate with another computing device via wireless communication techniques or directly with another computing device via a wired connection. In some examples, telemetry circuitry 308 provides wireless communication via RF or a proximal inductive medium. In some examples, telemetry circuitry 308 includes an antenna, which may take a variety of forms, such as an internal antenna or an external antenna.

[0123] Examples of local wireless communication technologies that can be used to facilitate communication between programmer 104 and IMD 106 include RF communication according to the 802.11 or Bluetooth specification sets or other standard or proprietary telemetry protocols. In this way, other external devices may be able to communicate with programmer 104 without establishing a secure wireless connection.

[0124] In some examples, processing circuitry 310 of external programmer 104 defines parameters of the electrical stimulation therapy stored in memory 311 to deliver adaptive DBS to patient 112. In one example, processing circuitry 310 of external programmer 104 issues commands to IMD 106 via telemetry circuitry 308, causing IMD 106 to deliver the electrical stimulation therapy via electrodes 116, 118, via leads 114.

[0125] In one or more examples, programmer 104 may be configured to perform one or more of the exemplary techniques described in the present disclosure. For example, processing circuit 310 may be configured to perform any of the exemplary operations described above with respect to processing circuit 210. For example, as described above, IMD 106 includes sensing circuit 204 for receiving bioelectric signals from one or more electrodes, and stimulation generation circuit 202 for delivering electrical stimulation having a final treatment parameter value. In some examples, telemetry circuit 308 may be configured to receive information of the bioelectric signal received by sensing circuit 204 (e.g., telemetry circuit 208 of IMD 106 may output information of the bioelectric signal to telemetry circuit 308 of programmer 104). Processing circuit 310 may perform the exemplary operations described above with respect to processing circuit 210 and determine a final treatment parameter value. Then, processing circuit 310 may cause telemetry circuit 308 to output the final treatment parameter value to IMD 106 so that electrical stimulation having the final treatment parameter value is delivered.

[0126] FIG. 4A to FIG. 4C is a conceptual diagram illustrating exemplary operations for determining a therapy parameter value according to an example of the presently disclosed technology. FIG. 4A to FIG. 4C One example of the lead 114A is shown as an example to aid understanding. FIG. 4A to FIG. 4C The electrodes on show an exemplary configuration of rDBSA electrodes.

[0127] Figure 4A An example of a waveform of a bioelectric signal recorded by the electrode 116 of the lead 114 is shown. The wave on the left side of the lead 114A and the wave on the right side show the incoming LFP signal. Figure 4B An example of an LFP source 402 that can generate a bioelectric signal sensed by electrode 116 is shown. Based on the sensed bioelectric signal, processing circuit 210 or 310 can determine which electrodes are closest to the signal source (e.g., LFP source 402) or have the highest CSD value. For example, assume that processing circuit 210 or 310 determines that electrodes 116A and 116B have the highest CSD value, and these electrodes are therefore considered to be closest to LFP source 402. The ring around LFP source 402 is used to illustrate that LFP source 402 can be an oscillating signal source.

[0128] In this example, stimulation generation circuit 202 and / or switching circuit 206 may deliver electrical stimulation using electrodes 116A and 116B. As one example, stimulation generation circuit 202 and / or switching circuit 206 may output electrical stimulation via segments of electrodes 116A and 116B that are selected based on which of electrodes 116A and 116B are closest to LFP source 402, thereby allowing for directional stimulation.

[0129] For example, Figure 4CAn example is shown of iteratively adjusting a therapeutic parameter value for amplitude (e.g., shown by the increasing size of the lightning bolt) to stimulate a large amount of neural tissue (shown by the dashed line) to suppress the beta band component of the bioelectric signal generated by the LFP source 402. In this way, the processing circuit 210 or 310 can adaptively titrate to the correct therapeutic parameter value for the amplitude of the electrical stimulation.

[0130] Figure 5 is a flowchart illustrating an exemplary operation of the technology according to the present disclosure. Figure 2 describe Figure 5 , such as where the medical device is IMD 106. However, the example techniques may implement other instances of a medical device, such as programmer 104.

[0131] As shown, the processing circuit 210 may determine a current power value (502) of power in a frequency band (e.g., a beta band from 13 Hz to 33 Hz in the bioelectric signal) generated in the brain 120 in response to the delivery of the current electrical stimulation with the current treatment parameter value. As an example, the processing circuit 210 may determine which electrodes are closest to a signal source (e.g., an LFP source) that generates the bioelectric signal or have the highest current source density (CSD) value. The electrode used for stimulation may be the same as the electrode that senses the bioelectric signal. The processing circuit 210 may select the determined electrode closest to the signal source for delivering the electrical stimulation. In order to determine the current power value of the power in the frequency band, the processing circuit 210 may receive information of the sensed bioelectric signal from one or more electrodes adjacent to one of the selected electrodes (e.g., the same axial level or a different axial level), and determine the current power value of the power in the frequency band based on the received information.

[0132] There may be various ways to determine the power in the frequency band. As an example, the processing circuit 210 may cause the stimulation generation circuit 202 and / or the switching circuit 206 to deliver the current electrical stimulation with the current therapeutic parameter value for a first time period of t seconds. During the delivery of the current electrical stimulation with the current therapeutic parameter value for the first time period of t seconds, the processing circuit 210 may determine a series of power level values ​​starting from a first portion of the first time period of t seconds. The first portion is after the start of the first time period. As an example, the processing circuit 210 may determine the series of power level values ​​starting from a midpoint of the first time period.

[0133] The processing circuit 210 may determine a current power value of the power in the frequency band based on the series of power level values ​​(e.g., such as based on an average of the power level values). For example, the processing circuit 210 may determine that the series of power level values ​​lasts for a second time period. In some examples, the second time period is equal to t seconds of the first time period.

[0134] Processing circuitry 210 may determine a power band difference between the current power value and the previous power value (504). The previous power value may indicate power in a frequency band in a previous bioelectric signal generated in brain 120 in response to delivery of a previous electrical stimulation having a previous treatment parameter value different from the current treatment parameter value. For example, prior to delivering electrical stimulation having the current treatment parameter value, IMD 106 may have delivered a previous electrical stimulation having the previous treatment parameter and determined power in a frequency band in the previous bioelectric signal. Processing circuitry 210 may store the previous power value in memory 211 as previous power value 216.

[0135] In one example, to determine the power band difference, processing circuit 210 may subtract previous power value 216 from current power value and determine an absolute value of the result. However, the example techniques are not limited in this regard.

[0136] Processing circuit 210 may compare the power band difference to a threshold value (506). The threshold value may be a tolerance value, wherein if the power band difference is less than the threshold value, patient 112 may not perceive any further adjustments to the current treatment parameter value, and any further adjustments to the treatment parameter value may result in little to no increase in treatment efficacy. However, if the power band difference is greater than or equal to the threshold value, further adjustments to the current treatment parameter value may be required.

[0137] Therefore, the processing circuit 210 may determine whether the power band difference is greater than or equal to a threshold value (508). Based on the power band difference being greater than or equal to the threshold value (508 being yes), the processing circuit 210 may adjust the current treatment value (510). For example, the processing circuit 210 may set the previous treatment parameter value equal to the current treatment parameter value, and adjust the current treatment parameter value based on the maximum of the previous treatment parameter value and the treatment parameter value. One such example is to use a binary search algorithm, where A=Amin+((Amax-Amin) / 2). In this example, A represents the new current treatment parameter value (e.g., the result of adjusting the current treatment parameter value), Amin represents the previous treatment parameter value (which is the current treatment parameter value before adjustment), and Amax is the maximum treatment parameter value. Other algorithms are possible in addition to or in lieu of the binary search algorithm. The processing circuit 210 may iteratively loop through Figure 5 In the example shown, the processing circuit 210 determines that the power band difference is less than the threshold value ( 508 : No).

[0138] Thus, the processing circuit 210 may iteratively set the previous treatment parameter value equal to the current treatment parameter value and adjust the current treatment parameter value until the power band difference is less than the threshold value. In some examples, the processing circuit 210 may adjust the current treatment parameter value based on the maximum treatment parameter value and possibly the previous treatment parameter value (which would be the current treatment parameter value before the adjustment).

[0139] Based on the power band difference being less than the threshold (No at 508), processing circuit 210 may set a final therapy parameter value based on the current therapy parameter value (512). Processing circuit 210 may then cause electrical stimulation to be delivered with the final therapy parameter value (514).

[0140] The techniques described in the present disclosure may be implemented at least in part in hardware, software, firmware, or any combination thereof. For example, various aspects of the techniques may be implemented in one or more processors, including one or more microprocessors, digital signal processors (DSPs), application specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), or any other equivalent integrated or discrete logic circuits, and any combination of such components. The term "processor" or "processing circuit" may generally refer to any of the aforementioned logic circuits or any other equivalent circuits, either alone or in combination with other logic circuits. A control unit including hardware may also perform one or more of the techniques of the present disclosure.

[0141] Such hardware, software, and firmware may be implemented in the same device or in separate devices to support the various operations and functions described in this disclosure. In addition, any of the units, modules, or components may be implemented together or individually as discrete but interoperable logical devices. Describing different features as modules or units is intended to highlight different functional aspects and does not necessarily imply that such modules or units must be implemented by separate hardware or software components. On the contrary, the functions associated with one or more modules or units may be performed by separate hardware or software components, or integrated in common or separate hardware or software components.

[0142] The techniques described in the present disclosure may also be embedded or encoded in a computer-readable medium (such as a computer-readable storage medium) containing instructions. The instructions embedded or encoded in the computer-readable storage medium may cause a programmable processor or other processor to perform the method, for example, when executing these instructions. The computer-readable storage medium may include a random access memory (RAM), a read-only memory (ROM), a programmable read-only memory (PROM), an erasable programmable read-only memory (EPROM), an electrically erasable programmable read-only memory (EEPROM), a flash memory, a hard disk, a CD-ROM, a floppy disk, a cassette, a magnetic medium, an optical medium, or other computer-readable medium.

[0143] Various examples have been described. These and other examples are within the scope of the following claims.

Claims

1. A method, comprising: determining, with processing circuitry, a current power value of power in a frequency band in a bioelectric signal generated in the brain in response to delivery of a current electrical stimulation having a current therapy parameter value; determining, with the processing circuitry, a power band difference between the current power value and a previous power value, wherein the previous power value indicates power in the frequency band in a previous bioelectric signal generated in the brain in response to delivery of a previous electrical stimulation having a previous therapy parameter value different from the current therapy parameter value, wherein the power band difference indicates a difference between the current power value and the previous power value; comparing the power band difference with a threshold value using the processing circuit; iteratively setting, with the processing circuit, the previous treatment parameter value to be equal to the current treatment parameter value based on the power band difference being greater than or equal to the threshold, and adjusting, with the processing circuit, the current treatment parameter value until the power band difference is less than the threshold; as well as A final treatment parameter value is set using the processing circuit based on the current treatment parameter value. 2 . The method according to claim 1 , wherein the frequency band is a β frequency band from 13 Hz to 33 Hz in the bioelectric signal.

3. The method according to any one of claims 1 to 2, wherein adjusting the current treatment parameter value comprises: determining maximum treatment parameter values; as well as The current treatment parameter value is iteratively adjusted based on a difference between the current treatment parameter value and the maximum treatment parameter value.

4. The method of any one of claims 1 to 2, further comprising causing, using the processing circuit, delivery of electrical stimulation having the final treatment parameter value.

5. The method according to claim 4, further comprising: Determining which electrodes are closest to a signal source generating the bioelectric signal or have a highest current source density (CSD) value; as well as selecting the determined electrodes for delivering the electrical stimulation, Wherein causing delivery of the electrical stimulation comprises causing delivery of the electrical stimulation using selected electrodes.

6. The method of claim 5, wherein determining the current power value of the power in the frequency band comprises: receiving information of the sensed bioelectric signal from one or more electrodes adjacent to one of the selected electrodes; as well as The current power value of the power in the frequency band is determined based on the received information.

7. The method of claim 4, wherein the delivery of the current electrical stimulation having the current therapy parameter value continues for a first time period of t seconds, and wherein determining the current power value of the power in the frequency band comprises: determining, during said delivery of said current electrical stimulation having said current therapy parameter value for said first time period lasting said t seconds, a series of power level values ​​starting from a first portion of said first time period of t seconds, wherein said first portion is after the start of said first time period; and The current power value of the power in the frequency band is determined based on the series of power level values.

8. The method of claim 7, wherein determining the series of power level values ​​comprises determining the series of power level values ​​starting from a midpoint in the first time period.

9. The method of claim 7, wherein determining the series of power level values ​​comprises determining the series of power level values ​​for a second time period, the second time period being equal to the t seconds of the first time period.

10. A system, comprising: A medical device, comprising: Memory; and A processing circuit, the processing circuit being configured to: determining a current power value of power in a frequency band in a bioelectric signal generated in the brain in response to delivery of a current electrical stimulation having a current therapy parameter value; determining a power band difference between the current power value and a previous power value, wherein the previous power value indicates power in the frequency band in a previous bioelectric signal generated in the brain in response to delivery of a previous electrical stimulation having a previous treatment parameter value different from the current treatment parameter value, and wherein the power value is stored in the memory, wherein the power band difference indicates a difference between the current power value and the previous power value; comparing the power band difference to a threshold value; iteratively setting the previous treatment parameter value to be equal to the current treatment parameter value based on the power band difference being greater than or equal to the threshold, and adjusting the current treatment parameter value until the power band difference is less than the threshold; Setting a final treatment parameter value based on the current treatment parameter value; and Such that electrical stimulation having said final treatment parameter value is delivered.

11. The system of claim 10, wherein the medical device comprises an implantable medical device (IMD), wherein the IMD comprises: a sensing circuit configured to receive the bioelectric signal from one or more electrodes; and A stimulation circuit is configured to deliver the electrical stimulation having the final treatment parameter value.

12. The system according to any one of claims 10 to 11, further comprising a programmer, wherein the programmer comprises: a telemetry circuit configured to receive the bioelectric signal and information of the previous bioelectric signal from an implantable medical device (IMD), and Wherein, to enable delivery of the electrical stimulation, the processing circuit is configured to cause the telemetry circuit to output the final therapy parameter value to the IMD. 13 . The system according to claim 10 , wherein the frequency band is a beta frequency band from 13 Hz to 33 Hz in the bioelectric signal.

14. The system according to any one of claims 10 to 11, wherein the processing circuit is configured to: Determining which electrodes are closest to a signal source generating the bioelectric signal or have the highest current source density (CSD) value; and selecting the determined electrodes for delivering the electrical stimulation, Wherein to enable delivery of the electrical stimulation, the processing circuit is configured to enable delivery of the electrical stimulation using the selected electrodes.

15. The system according to any one of claims 10 to 11, wherein in order to determine the current power value of the power in the frequency band, the processing circuit is configured to: receiving information of the sensed bioelectric signal from one or more electrodes adjacent to one of the selected electrodes; and The current power value of the power in the frequency band is determined based on the received information.

16. The system of any one of claims 10 to 11, wherein the delivery of the current electrical stimulation having the current therapy parameter value lasts for a first time period of t seconds, and wherein to determine the current power value of the power in the frequency band, the processing circuit is configured to: determining, during said delivery of said current electrical stimulation having said current therapy parameter value for said first time period lasting said t seconds, a series of power level values ​​starting from a first portion of said first time period of t seconds, wherein said first portion is after the start of said first time period; and The current power value of the power in the frequency band is determined based on the series of power level values.

17. The system of claim 16, wherein to determine the series of power level values, the processing circuit is configured to determine the series of power level values ​​starting from a midpoint in the first time period.

18. The system of claim 16, wherein to determine the series of power level values, the processing circuit is configured to determine a second time period for the series of power level values, the second time period lasting equal to the t seconds of the first time period.

19. The system of any one of claims 10 to 11, wherein to adjust the current treatment parameter value, the processing circuit is configured to: determining a maximum treatment parameter value; and The current treatment parameter value is iteratively adjusted based on a difference between the current treatment parameter value and the maximum treatment parameter value.

20. A computer-readable storage medium storing instructions that, when executed, cause one or more processors of a medical device to: determining a current power value of power in a frequency band in a bioelectric signal generated in the brain in response to delivery of a current electrical stimulation having a current therapy parameter value; determining a power band difference between the current power value and a previous power value, wherein the previous power value is indicative of power in the frequency band in a previous bioelectric signal generated in the brain in response to delivery of a previous electrical stimulation having a previous therapy parameter value different from the current therapy parameter value, wherein the power band difference is indicative of a difference between the current power value and the previous power value; comparing the power band difference to a threshold value; iteratively setting the previous treatment parameter value to be equal to the current treatment parameter value based on the power band difference being greater than or equal to the threshold, and adjusting the current treatment parameter value until the power band difference is less than the threshold; Setting a final treatment parameter value based on the current treatment parameter value; as well as Such that electrical stimulation having said final treatment parameter value is delivered. 21 . The computer-readable storage medium of claim 20 , wherein the frequency band is a beta frequency band from 13 Hz to 33 Hz in the bioelectric signal.

22. The computer-readable storage medium of any one of claims 20 to 21, further comprising instructions that cause the one or more processors to: Determining which electrodes are closest to a signal source generating the bioelectric signal or have the highest current source density (CSD) value; and selecting the determined electrodes for delivering the electrical stimulation, Wherein the instructions to cause the one or more processors to cause the electrical stimulation to be delivered include instructions to cause the one or more processors to cause the electrical stimulation to be delivered utilizing selected electrodes.

23. The computer-readable storage medium of claim 22, wherein the instructions causing the one or more processors to determine the current power value of the power in the frequency band comprise instructions causing the one or more processors to: receiving information of the sensed bioelectric signal from one or more electrodes adjacent to one of the selected electrodes; and The current power value of the power in the frequency band is determined based on the received information.

24. The computer-readable storage medium of any one of claims 20 to 21, wherein the delivery of the current electrical stimulation having the current therapy parameter value lasts for a first time period of t seconds, and wherein the instructions causing the one or more processors to determine the current power value of the power in the frequency band comprise instructions causing the one or more processors to: determining, during said delivery of said current electrical stimulation having said current therapy parameter value for said first time period lasting said t seconds, a series of power level values ​​starting from a first portion of said first time period of t seconds, wherein said first portion is after the start of said first time period; and The current power value of the power in the frequency band is determined based on the series of power level values.

Citation Information

Patent Citations

  • Electrode selection based on current source density analysis

    US20140074187A1

  • Medical therapy target definition

    US20170259064A1

  • Medical device configuration based on sensed brain signals

    US20090112281A1

  • Psychiatric disorder therapy control

    US20090264956A1

  • Mood circuit monitoring to control therapy delivery

    US20100114237A1